More on ATHE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Alterity Therapeutics (NQ:ATHE)
Delayed: 4.88 -0.26 (5.06%)
Prev. Close $5.14  
Open$5.05 
52 Wk High$ 
52 Wk Low$ 
Day High$5.10 
Day Low$4.82 
P/E N/A  
EPS$ 
Volume19,285 

Friends, Peers and Foes (?): PBN, ATH ATH.AX (more...)

Jun 16, 2026 08:04 AM Ladenburg Thalmann Assumes Alterity Therapeutics (ATHE) at Buy
Jun 3, 2026 06:05 AM Form 6-K ALTERITY THERAPEUTICS For: Jun 30
May 29, 2026 06:08 AM Form 6-K ALTERITY THERAPEUTICS For: May 31
May 19, 2026 07:25 AM Alterity Therapeutics presents data supporting ATH434 Phase 3 advance in MSA
May 19, 2026 07:25 AM Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy
May 19, 2026 06:06 AM Form 6-K ALTERITY THERAPEUTICS For: May 31
May 12, 2026 03:40 PM Form 424B3 Alterity Therapeutics
May 12, 2026 06:07 AM Form 6-K ALTERITY THERAPEUTICS For: May 31
May 11, 2026 07:25 AM Alterity publishes study on MRI biomarker for multiple system atrophy
May 11, 2026 07:25 AM Alterity Therapeutics Announces Publication Demonstrating the Utility of Quantitative MRI as a Biomarker for Multiple System Atrophy
View All Articles

Entities mentioned with ATHE

View All Entities